Detail of the clinical trial
| Title of the trial | A phase III, multicenter, randomized, placebo-controlled, double-blind study of atezolizumab (anti-PD-L1 antibody) as adjuvant therapy in patients with renal cell carcinoma at high risk of developing metastasis following nephrectomy |
|---|---|
| EudraCT number | 2016-001881-27 |
| Protocol number | WO39210 |
| Sponsor | F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland |
| Indications | Oncology |
| Diagnosis | renal cell carcinoma |
| Population in clinical trial |
Adults (18-65 years) Elderly ( > 65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2017 |
| Date of approval by Institute (SÚKL) | 14.2.2017 |
| Date of approval by EC | 8.2.2017 |
| Date of initiation CT in ČR | 18.5.2017 |
| Date of ending CT in ČR | |
| Notice | |
| Sites |
FN Brno-Interní hemato onkologická klinika, Jihlavská 20 , Brno 62500 FN Motol-Onko.klinika 2.LF UK V Úvalu 84/1 Praha 5 15606 Nemocnice AGEL Nový Jičín a.s. -oddělení radioterapie a onkologie, Purkyňova 2138/16, Nový Jičín 741 01 Nemocnice na Bulovce-Ústav radiační onkologie, Budínova 67/2, Praha 8, 180 81 Masarykuv onkologický ústav, Žlutý kopec 7,Brno,65653, (discontinued) Vseobecna fakultni nemocnice v Praze,Onkologická klinika VFN a 1. LF UK,U Nemocnice 2,Praha 2,12808 Thomayerova Nemocice,Onkologická Klinika 1.LF UK,Videnska 800,Praha,14059 (discontinued) Fakultni Nemocnice Olomouc,Onkologická klinika,I. P. Pavlova 6,Olomouc,77520 (discontinued) Fakultní nemocnice Královské Vinohrady,Radioterapeutická a onkologická klinika,Šrobárova 1150,Praha 10,10034 (discontinued) |
cz